-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Entering 2022, most companies are conducting year-end summaries and New Year's plans; it is worth noting that many companies are also actively recruiting
.
Ruhuizhi Medicine is recruiting medical information communication specialists to be responsible for all products in the hospital community
.
CSPC's anti-tumor drug business department is recruiting academic representatives/senior academic representatives to be responsible for the sales of Duomex
.
In the job requirements, it is clearly stated that they should be representatives of medicine-related majors and have more than 2 years of clinical drug sales experience, and those with special tumor drug sales experience are preferred
.
In 2022, pharmaceutical companies will still have strong demand for the recruitment of pharmaceutical representatives (Source: Pharmaceutical Network) and Chia Tai Tianqing Pharmaceutical Group is also recruiting academic specialists to be responsible for the company's anticoagulant product dabigatran and hypoglycemic product saxagliptin (the winning product), respiratory antibiotic products,
etc.
In addition to the above companies, Concord Kirin, AstraZeneca Pharmaceutical Co.
, Ltd.
, Sino-US Huadong, Menarini (China), Fosun Pharma, etc.
are also recruiting professionals for different positions, including academic information specialists, medical information communication specialists, Regional managers, promotion managers, medical representatives,
etc.
On the whole, pharmaceutical companies have a greater demand for pharmaceutical representatives
.
Industry analysts believe that judging from the current recruitment positions of major pharmaceutical companies, it can be clearly found that pharmaceutical companies are indeed paying more attention to the transmission of product information and improving their sensitivity to the market
.
Therefore, in order to stabilize revenue, the goal of many pharmaceutical companies will be to accelerate the increase in product sales, or will strengthen the construction of marketing teams and conduct professional marketing to continuously increase regional coverage and market share
.
Affected by this, the demand for medical representatives and senior medical talents is also increasing
.
However, it should be noted that with the continuous advancement of medical reform, the two-invoice system, volume-based procurement, and the DRGs system, the environment for medical representatives is undergoing tremendous changes, and the entire group is also facing more and more challenges
.
For example, from the perspective of relevant policies and regulations, my country is vigorously cracking down on the illegal behavior of medical representatives, which has led to more and more constraints on the promotion of a large number of medical representatives.
.
In addition, with the development of Internet technology, artificial intelligence, and the advent of the era of digital pharmaceutical companies, many pharmaceutical companies are also striving to create "smart Internet virtual pharmaceutical representatives", that is, pharmaceutical digital marketing, which has also led to the traditional marketing of domestic pharmaceutical representatives.
method has been greatly affected
.
However, in general, although policies such as bulk procurement, generic drug consistency evaluation, and key monitoring have impacted the original working environment of medical representatives to a certain extent, and eliminated a large number of medical representatives
.
However, in the context of the rapid development of the pharmaceutical industry, it is generally believed in the industry that there will still be a strong demand for the recruitment of pharmaceutical representatives by pharmaceutical companies
.
There is still a lot of work in a large number of places that needs to be carried out by medical representatives
.
Therefore, for medical representatives, what needs to be done now is compliance development, and by returning to academic promotion, and continuously improving professional capabilities, so as to help enterprises achieve better development
.
.
Ruhuizhi Medicine is recruiting medical information communication specialists to be responsible for all products in the hospital community
.
CSPC's anti-tumor drug business department is recruiting academic representatives/senior academic representatives to be responsible for the sales of Duomex
.
In the job requirements, it is clearly stated that they should be representatives of medicine-related majors and have more than 2 years of clinical drug sales experience, and those with special tumor drug sales experience are preferred
.
In 2022, pharmaceutical companies will still have strong demand for the recruitment of pharmaceutical representatives (Source: Pharmaceutical Network) and Chia Tai Tianqing Pharmaceutical Group is also recruiting academic specialists to be responsible for the company's anticoagulant product dabigatran and hypoglycemic product saxagliptin (the winning product), respiratory antibiotic products,
etc.
In addition to the above companies, Concord Kirin, AstraZeneca Pharmaceutical Co.
, Ltd.
, Sino-US Huadong, Menarini (China), Fosun Pharma, etc.
are also recruiting professionals for different positions, including academic information specialists, medical information communication specialists, Regional managers, promotion managers, medical representatives,
etc.
On the whole, pharmaceutical companies have a greater demand for pharmaceutical representatives
.
Industry analysts believe that judging from the current recruitment positions of major pharmaceutical companies, it can be clearly found that pharmaceutical companies are indeed paying more attention to the transmission of product information and improving their sensitivity to the market
.
Therefore, in order to stabilize revenue, the goal of many pharmaceutical companies will be to accelerate the increase in product sales, or will strengthen the construction of marketing teams and conduct professional marketing to continuously increase regional coverage and market share
.
Affected by this, the demand for medical representatives and senior medical talents is also increasing
.
However, it should be noted that with the continuous advancement of medical reform, the two-invoice system, volume-based procurement, and the DRGs system, the environment for medical representatives is undergoing tremendous changes, and the entire group is also facing more and more challenges
.
For example, from the perspective of relevant policies and regulations, my country is vigorously cracking down on the illegal behavior of medical representatives, which has led to more and more constraints on the promotion of a large number of medical representatives.
.
In addition, with the development of Internet technology, artificial intelligence, and the advent of the era of digital pharmaceutical companies, many pharmaceutical companies are also striving to create "smart Internet virtual pharmaceutical representatives", that is, pharmaceutical digital marketing, which has also led to the traditional marketing of domestic pharmaceutical representatives.
method has been greatly affected
.
However, in general, although policies such as bulk procurement, generic drug consistency evaluation, and key monitoring have impacted the original working environment of medical representatives to a certain extent, and eliminated a large number of medical representatives
.
However, in the context of the rapid development of the pharmaceutical industry, it is generally believed in the industry that there will still be a strong demand for the recruitment of pharmaceutical representatives by pharmaceutical companies
.
There is still a lot of work in a large number of places that needs to be carried out by medical representatives
.
Therefore, for medical representatives, what needs to be done now is compliance development, and by returning to academic promotion, and continuously improving professional capabilities, so as to help enterprises achieve better development
.
